Allergan, Syntex involved in patent monopoly case

October 15, 2003

San Francisco-A federal judge will decide this fall whether a generic formulation of ketorolac tromethamine violates a patent held by Syntex Pharmaceuticals and licensed to Allergan Inc. to make Acular.